We’ve just had three more peer reviewed research papers published in prestigious scientific journals. That makes 16 this year, easily a record by a GcMAF organisation.
Rather excitingly for those with ME/CFS, in the American Journal of Immunology, “Effects of GcMAF on human neurons and ME/CFS treatment.” Published the 8th November. This will, with our other discoveries, take our success with ME to above 70%.
Group component protein-derived macrophage activating factor stimulates macrophages that induce human breast cancer cell apoptosis.
M. Ruggiero, L. Thyer, E. Ward, R. Smith, J.J.V. Branca, M. Gulisano, G. Morucci, S. Pacini.
Intl. J. Gynecol. Cancer. ECCO meeting abstr. 2013. Ovarian and Breast Cancer. P. 140.
and the third:
Vitamin D binding protein-derived macrophage activating factor inhibits human breast cancer cell proliferation and decreases alpha-N-acetyl galactosaminidase in breast cancer patiens
L. Thyer, G. Morucci, J.J.V. Branca, E. Ward, R. Smith, D. Noakes
Intl. J. Gynecol. Cancer. ECCO meeting abstr. 2013. Ovarian and Breast Cancer. P. 145.